Covid 19 Infection In A Patient Newly Diagnosed With Hiv Tb Coinfection – A Case Report
DOI:
https://doi.org/10.48165/ijabms.2022.243816Keywords:
HIV/TB coinfection, COVID 19 with HIV/TB, immune reconstitution inflammatory syndrome (IRIS), TB lymphadenopathyAbstract
Introduction -COVID 19 refers to infectious disease caused due to infection by SARS-CoV-2, which resulted in a pandemic in the year 2020, with continuing effects in some regions of the world. It chiefly causes a respiratory illness, with features ranging from fever and mild cough to breathlessness and hypoxemia, along with a secondary hyperinflammatory and hypercoagulable state. HIV/TB coinfection is, on its own, associated with a poor outcome, due to an increased propensity to secondary infections. Method & Discussion :Here, we describe the case of an elderly male admitted for COVID 19, but diagnosed as having HIV/TB coinfection, with generalised lymphadenopathy and other constitutional features. Treatment was instituted per protocol. He also developed a treatment-related immune reconstitution inflammatory syndrome (IRIS), which was appropriately managed, and was eventually discharged following recovery from COVID-19. ART and AKT, with prophylactic medications, were ongoing at the time of discharge.
Conclusion :– HIV/TB coinfection is associated with a poor prognosis. There are no specific recommendations for management of superadded COVID-19. The number of reported cases is low, and treatment had been given for the respective disorders as per prevailing local protocols.
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Shivam Sanjay Panchal, Janakkumar R Khambholja, Nehal M Shah, Poorvi Mansukhbhai Aghara
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.